Halma plc 25.6% Potential Decrease Indicated by JP Morgan Cazenove

Broker Ratings

Halma plc with EPIC/TICKER (LON:HLMA) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘UNDERWEIGHT’ this morning by analysts at JP Morgan Cazenove. Halma plc are listed in the Industrials sector within UK Main Market. JP Morgan Cazenove have set their target price at 1370 GBX on its stock. This now indicates the analyst believes there is a potential downside of -25.6% from the opening price of 1842.5 GBX. Over the last 30 and 90 trading days the company share price has decreased 302.5 points and decreased 329.5 points respectively. The 52 week high for the share price is currently at 2261 GBX while the 52 week low for the share price is 1641.48 GBX.

Halma plc has a 50 day moving average of 2,106.02 GBX and the 200 Day Moving Average price is recorded at 2,038.22. There are currently 449,309,833 shares in issue with the average daily volume traded being 1,522,788. Market capitalisation for LON:HLMA is £6,826,022,494 GBP.

Share on:
Find more news, interviews, share price & company profile here for:

    Halma Plc CFO Steve Gunning to retire, Carole Cran appointed as CFO Designate

    Halma plc announces CFO transition with Steve Gunning retiring in 2025 and Carole Cran stepping in, continuing the company's growth strategy.

    Halma plc achieves record H1 results, continued dividend growth

    Halma plc (LON:HLMA) reports strong half-year results, announcing a 7% interim dividend increase, boosting shareholder returns in 2024.

    Halma Plc acquires Lamidey Noury, enhancing minimally invasive surgical solutions

    Halma Plc acquires Lamidey Noury Medical, expanding its healthcare portfolio with advanced electrosurgical devices for minimally invasive procedures.

      Search

      Search